Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025 2026
Market Cap 1 91.84 79.88
Change - -13.02%
Enterprise Value (EV) 1 61.1 64.14
Change - 4.98%
P/E 21.2x 19.1x
PBR 1.04x 0.86x
PEG -1.1x -5.48x
Capitalization / Revenue 1.12x 0.84x
EV / Revenue 0.74x 0.68x
EV / EBITDA 7.34x 6.31x
EV / EBIT 16x 12.6x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 1.896 1.83
Distribution rate - -
Net sales 1 82.35 94.91
EBITDA 1 8.319 10.16
EBIT 1 3.821 5.079
Net income 1 3.947 4.179
Net Debt 1 -30.75 -15.75
Reference price 2 40.24 35.00
Nbr of stocks (in thousands) 2,282 2,282
Announcement Date 26/8/25 22/8/26
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 754K
12.77x0.39x8.22x3.03% 112B
15.03x1.86x9.3x0.7% 96.35B
-276.43x18.99x-322.89x-.--% 56.33B
12.69x1.42x8.57x2.81% 26.23B
22.55x2.08x11.9x0.93% 25.48B
22.7x2.54x12.88x1.43% 25.48B
31.28x5.67x23.55x2.23% 21.32B
7.91x1.43x6.48x-.--% 20.98B
20.94x1.86x9.37x3.33% 19.83B
Average -14.50x 4.03x -25.85x 1.61% 40.43B
Weighted average by Cap. -24.62x 4.05x -36.33x 1.62%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Clinitech Laboratory Limited

Historical PBR trend

Valuation ratios - PBR - Clinitech Laboratory Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Clinitech Laboratory Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Clinitech Laboratory Limited

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited